Palmitoyl Tripeptide-1 vs GHK-Cu
The same GHK sequence with two different delivery strategies.
The distinction that mattersSame GHK tripeptide, different delivery. GHK-Cu carries a copper ion and works partly through copper delivery; palmitoyl tripeptide-1 carries a fatty tail for penetration and has no copper component.
| Palmitoyl Tripeptide-1 Cosmetic Ingredient | GHK-Cu Cosmetic Ingredient | |
|---|---|---|
| Evidence rating |
3/5 Moderate
Evidence rating 3 out of 5: Moderate
|
3/5 Moderate
Evidence rating 3 out of 5: Moderate
|
| Regulatory status | Widely used cosmetic ingredient, typically paired with palmitoyl tetrapeptide-7 in commercial formulations. | Established cosmetic ingredient with human topical data. Injectable use is unapproved and unstudied. |
| Category | Skin & Cosmetic | Skin & Cosmetic |
| Drug class | Lipidated tripeptide — the GHK sequence conjugated to palmitic acid | Naturally occurring copper-binding tripeptide |
| Route | Topical | Topical (well studied); injectable (not studied) |
| Half-life | Not applicable — topical | Topical residence measured in hours; declines with age in plasma |
| Studied in | Controlled topical studies of the combination product measuring wrinkle depth and dermal density; fibroblast and ex-vivo skin work. | Multiple controlled topical trials in facial photoaging, wound healing, and hair growth; extensive fibroblast and gene-expression work. |
| Who should avoid it |
|
|
| Legal status | Lawful cosmetic ingredient. | Lawful as a cosmetic ingredient. Injectable preparations are unapproved. |
Benefits — Palmitoyl Tripeptide-1
- Wrinkle depth reduction in controlled studies
Combination products showed measurable improvement in wrinkle depth and skin smoothness versus vehicle over 8–12 weeks.
- Collagen and matrix stimulation
Consistent fibroblast data for increased collagen I, III and IV, plus fibronectin and hyaluronic acid.
- Better penetration than unmodified GHK
The palmitoyl chain solves the delivery problem that limits most topical peptides.
- Complementary anti-inflammatory partner
The paired tetrapeptide-7 targets IL-6-driven matrix degradation, a different mechanism from collagen stimulation.
- Very well tolerated
Suitable for sensitive skin and compatible with most other actives.
Benefits — GHK-Cu
- Improved skin firmness and wrinkle depth
Controlled facial trials with copper-peptide creams showed measurable improvements in wrinkle depth, skin density and elasticity versus vehicle.
- Wound healing acceleration
Human and animal studies show faster closure and better-organised collagen deposition in wounds.
- Collagen and elastin stimulation
Robust fibroblast data showing upregulation of matrix synthesis.
- Hair follicle effects
Small studies suggest increased follicle size and hair density with topical application.
- Antioxidant and anti-inflammatory activity
Reduces oxidative damage markers in laboratory models.
Risks & cons — Palmitoyl Tripeptide-1
- Effect sizes are modest
Real but incremental. It will not approach the results of retinoids at effective concentrations, or procedural treatments.
- Evidence largely from ingredient suppliers
Most supporting studies are manufacturer-sponsored, and independent replication is limited.
- Combination products obscure attribution
Because it is nearly always sold with tetrapeptide-7, the individual contribution of each peptide is unclear.
- Concentration rarely disclosed
Products vary widely and often contain far less than the studied concentration.
- Requires continuous use
Benefits regress once application stops.
Risks & cons — GHK-Cu
- Injectable use has no evidence base
The credible data is topical. Injecting copper peptides for systemic anti-aging has not been studied and introduces copper-load questions.
- Copper accumulation concern
Chronic high-dose systemic copper exposure carries hepatic and neurologic risk; contraindicated in Wilson disease.
- Skin irritation and contact dermatitis
Occurs in a minority of topical users, more often at higher concentrations.
- Incompatibility with vitamin C and some acids
Direct co-application can destabilise the complex; separate application times are advised.
- Wide variation in product concentration
Cosmetic products differ enormously in actual GHK-Cu content and formulation quality.
A comparison is not a recommendation. Neither column is being suggested for you. Which — if either — is appropriate depends on your diagnosis, history and medications, and that is a conversation for a qualified clinician.